Grapefruit itself has a low glycaemic index and contains beneficial nutrients, but portion control remains important
Clinical trials (SURPASS and SURMOUNT programmes) have shown that dual agonists may offer improved glycaemic control and weight reduction compared to GLP-1 monotherapy
Semaglutide shortage update.
Common APIs in this subcategory include biguanides, sulfonylureas, thiazolidinediones, dipeptidyl peptidase-4 (DPP-4) inhibitors, glucagon-like peptide-1 (GLP-1) receptor agonists, and sodium-glucose co-transporter 2 (SGLT2) inhibitors
Respiratory & Gastrointestinal Care COPD: Salbutamol, Formoterol, Tiotropium, Ipratropium, and Budesonide